Literature DB >> 32841579

Cytokines and COVID-19: friends or foes?

Mohsen Rokni1, Michael R Hamblin2,3, Nima Rezaei1,4,5.   

Abstract

The cytokine storm following sepsis has been proven to be an important mechanism for triggering acute respiratory distress syndrome, which is a fatal uncontrolled systemic inflammation characterized by high concentrations of pro-inflammatory cytokines and chemokines, secreted by immune effector cells. The cytokine storm also occurs in the recently emerged novel coronavirus disease (COVID-19). Therefore, cytokines which usually help the immune system to fight infections are potentially harmful in the course of COVID-19 infections. Therefore, avoiding or mitigating the cytokine storm may be a key treatment for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Entities:  

Keywords:  COVID-19; Cytokine storm; chemokines; pro-inflammatory cytokines; severe acute respiratory syndrome coronavirus 2

Mesh:

Substances:

Year:  2020        PMID: 32841579      PMCID: PMC7644241          DOI: 10.1080/21645515.2020.1799669

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  22 in total

Review 1.  Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications.

Authors:  Ying Wang; Xiaodong Chen; Wei Cao; Yufang Shi
Journal:  Nat Immunol       Date:  2014-11       Impact factor: 25.606

2.  Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome.

Authors:  Laurence Fardet; Lionel Galicier; Olivier Lambotte; Christophe Marzac; Cedric Aumont; Doumit Chahwan; Paul Coppo; Gilles Hejblum
Journal:  Arthritis Rheumatol       Date:  2014-09       Impact factor: 10.995

3.  Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection.

Authors:  Jun Chen; Yuk Fai Lau; Elaine W Lamirande; Christopher D Paddock; Jeanine H Bartlett; Sherif R Zaki; Kanta Subbarao
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

4.  COVID-19: Developing from an Outbreak to A Pandemic.

Authors:  Sara Hanaei; Nima Rezaei
Journal:  Arch Med Res       Date:  2020-05-13       Impact factor: 2.235

5.  Human immunopathogenesis of severe acute respiratory syndrome (SARS).

Authors:  Mark J Cameron; Jesus F Bermejo-Martin; Ali Danesh; Matthew P Muller; David J Kelvin
Journal:  Virus Res       Date:  2007-03-19       Impact factor: 3.303

6.  Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.

Authors:  Qiurong Ruan; Kun Yang; Wenxia Wang; Lingyu Jiang; Jianxin Song
Journal:  Intensive Care Med       Date:  2020-03-03       Impact factor: 17.440

Review 7.  Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology.

Authors:  Rudragouda Channappanavar; Stanley Perlman
Journal:  Semin Immunopathol       Date:  2017-05-02       Impact factor: 9.623

Review 8.  T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV.

Authors:  William J Liu; Min Zhao; Kefang Liu; Kun Xu; Gary Wong; Wenjie Tan; George F Gao
Journal:  Antiviral Res       Date:  2016-11-11       Impact factor: 5.970

9.  Pathological findings of COVID-19 associated with acute respiratory distress syndrome.

Authors:  Zhe Xu; Lei Shi; Yijin Wang; Jiyuan Zhang; Lei Huang; Chao Zhang; Shuhong Liu; Peng Zhao; Hongxia Liu; Li Zhu; Yanhong Tai; Changqing Bai; Tingting Gao; Jinwen Song; Peng Xia; Jinghui Dong; Jingmin Zhao; Fu-Sheng Wang
Journal:  Lancet Respir Med       Date:  2020-02-18       Impact factor: 30.700

10.  SARS-CoV-2-A Tough Opponent for the Immune System.

Authors:  Mahsa Golshani Nasab; Amene Saghazadeh; Nima Rezaei
Journal:  Arch Med Res       Date:  2020-05-30       Impact factor: 2.235

View more
  21 in total

Review 1.  Interferon therapy in patients with SARS, MERS, and COVID-19: A systematic review and meta-analysis of clinical studies.

Authors:  Kiarash Saleki; Shakila Yaribash; Mohammad Banazadeh; Ehsan Hajihosseinlou; Mahdi Gouravani; Amene Saghazadeh; Nima Rezaei
Journal:  Eur J Pharmacol       Date:  2021-06-12       Impact factor: 4.432

Review 2.  The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication.

Authors:  Qin Ning; Di Wu; Xiaojing Wang; Dong Xi; Tao Chen; Guang Chen; Hongwu Wang; Huiling Lu; Ming Wang; Lin Zhu; Junjian Hu; Tingting Liu; Ke Ma; Meifang Han; Xiaoping Luo
Journal:  Signal Transduct Target Ther       Date:  2022-02-23

Review 3.  Biosensing surfaces and therapeutic biomaterials for the central nervous system in COVID-19.

Authors:  Amene Saghazadeh; Nima Rezaei
Journal:  Emergent Mater       Date:  2021-03-10

4.  Comparison of clinical, para-clinical and laboratory findings in survived and deceased patients with COVID-19: diagnostic role of inflammatory indications in determining the severity of illness.

Authors:  Mohsen Rokni; Kazem Ahmadikia; Somaye Asghari; Shahabodin Mashaei; Fahimeh Hassanali
Journal:  BMC Infect Dis       Date:  2020-11-23       Impact factor: 3.090

Review 5.  Computational drug discovery and repurposing for the treatment of COVID-19: A systematic review.

Authors:  Kawthar Mohamed; Niloufar Yazdanpanah; Amene Saghazadeh; Nima Rezaei
Journal:  Bioorg Chem       Date:  2020-11-19       Impact factor: 5.275

6.  Immune checkpoint inhibition in COVID-19: risks and benefits.

Authors:  Parmida Sadat Pezeshki; Nima Rezaei
Journal:  Expert Opin Biol Ther       Date:  2021-02-17       Impact factor: 4.388

Review 7.  Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches.

Authors:  Amal Hasan; Ebaa Al-Ozairi; Zahraa Al-Baqsumi; Rasheed Ahmad; Fahd Al-Mulla
Journal:  Immunotargets Ther       Date:  2021-03-09

8.  Inflammation and tumor progression: signaling pathways and targeted intervention.

Authors:  Huakan Zhao; Lei Wu; Guifang Yan; Yu Chen; Mingyue Zhou; Yongzhong Wu; Yongsheng Li
Journal:  Signal Transduct Target Ther       Date:  2021-07-12

Review 9.  Eosinophils and COVID-19: diagnosis, prognosis, and vaccination strategies.

Authors:  Helene F Rosenberg; Paul S Foster
Journal:  Semin Immunopathol       Date:  2021-03-16       Impact factor: 9.623

10.  COVID-19 and the Risk of Relapse in Multiple Sclerosis Patients: A Fight with No Bystander Effect?

Authors:  Masoud Etemadifar; Nahad Sedaghat; Ali Aghababaee; Parisa K Kargaran; Mohammad Reza Maracy; Mazdak Ganjalikhani-Hakemi; Milad Rayani; Amir Parsa Abhari; Reza Khorvash; Mehri Salari; Hosein Nouri
Journal:  Mult Scler Relat Disord       Date:  2021-03-20       Impact factor: 4.339

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.